SION compared with CBLL: revenue, margins and what each company keeps, and the suppliers and customers both name

SIONSionna Therapeutics, Inc.

Mkt capRevenueRevenue

CBLLCeribell, Inc.

Mkt capRevenueRevenue

Compare

SIONSionna Therapeutics, Inc.

CBLLCeribell, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SION

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▲+4.80%—

May 12 '26±10.9%▼−10.90%×1.00

Q1 FY26—▼−7.17%—

Nov 5 '25—▼−1.57%—

CBLL

1 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▼−3.11%—

Q2 FY26±13.1%▲+10.41%×0.79

= impliedSION realized, solidCBLL realized, hatchedOne scale, both sides: full bar = 17%× = |realized| ÷ impliedSource: market data

May 12 '26

±13.1%

▼−16.50%

×1.26

Q1 FY26±13.4%▼−4.77%×0.36

SIONSionna Therapeutics, Inc.

3.27▼−0.38%· post 3.23

Mkt cap$148.1MRevenue—Revenue—

CBLLCeribell, Inc.

26.66▲+2.50%· post 26.64

ClosedNov 6 '26

Mkt cap$1.0BRevenue$29MQ3 FY26Revenue$89MFY25

Compare

ClosedNov 6 '26

SIONSionna Therapeutics, Inc.

CBLLCeribell, Inc.

3.27▼−0.38%post 3.23

Price

26.66▲+2.50%post 26.64

$148.1M

Mkt cap

$1.0B

—

Revenue

$29MQ3 FY26

—

Revenue

$89MFY25

SION3.27▼−0.38%vsCBLL26.66▲+2.50%ClosedNov 6 '26